SpliceBio

Barcelona, Spain · Founded 2012 · Privately Held (backing)

Operator of a biotechnology company intended to develop genetic medicines through protein-splicing gene therapy. SpliceBio is based in Barcelona, Spain and was founded in 2012. Its last reported valuation was $84.5 million in Feb 2022. It has raised $198 million.

Last reported valuation

$84.5M

Oct 2026

Priced at

—

Total raised

$198.0M

Last round

—

How much has SpliceBio raised?

$198.0Macross 0 recorded rounds

Free account

More of SpliceBio with a free account

·The complete investor list: 11 names
·Watch SpliceBio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

SpliceBio investors

11 investors are on record for SpliceBio, including New Enterprise Associates, EQT Life Sciences, Gilde Healthcare and Novartis Venture Fund.

For fundraisers

Raising for a company like SpliceBio?

11 investors have backed SpliceBio.

See all 11 investors →

Frequently asked about SpliceBio

How much has SpliceBio raised?: SpliceBio has raised $198.0M in total across 0 recorded funding rounds.